{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:45:33Z","timestamp":1792633533344,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["NCI (P30 CA008748)"],"award-info":[{"award-number":["NCI (P30 CA008748)"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11060-022-04101-9","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T15:11:51Z","timestamp":1658934711000},"page":"609-618","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases"],"prefix":"10.1007","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1281-5915","authenticated-orcid":false,"given":"Brandon S.","family":"Imber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7003-3017","authenticated-orcid":false,"given":"Robert J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1258-6112","authenticated-orcid":false,"given":"Anne S.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-8502","authenticated-orcid":false,"given":"Alexandra M.","family":"Giantini-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan T.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Aramburu-Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4252-6855","authenticated-orcid":false,"given":"Gil\u2019ad N.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-8891","authenticated-orcid":false,"given":"Cameron","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1284-1670","authenticated-orcid":false,"given":"Viviane","family":"Tabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0930-1681","authenticated-orcid":false,"given":"Nelson S.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"4101_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1602\/neurorx.2.1.86","volume":"2","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher W, Potschka H (2005) Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2:86\u201398. https:\/\/doi.org\/10.1602\/neurorx.2.1.86","journal-title":"NeuroRx"},{"key":"4101_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.adro.2019.07.012","volume":"5","author":"AB Barbour","year":"2020","unstructured":"Barbour AB, Jacobs CD, Williamson H et al (2020) Radiation therapy practice patterns for brain metastases in the United States in the stereotactic radiosurgery era. Adv Radiat Oncol 5:43\u201352. https:\/\/doi.org\/10.1016\/j.adro.2019.07.012","journal-title":"Adv Radiat Oncol"},{"key":"4101_CR3","doi-asserted-by":"publisher","first-page":"e13590","DOI":"10.1200\/JCO.2019.37.15_suppl.e13590","volume":"37","author":"K O\u2019Connell","year":"2019","unstructured":"O\u2019Connell K, Romo CG, Grossman SA (2019) Brain metastases as a first site of recurrence in patients on chemotherapy with controlled systemic cancers: an increasingly urgent clinical scenario. J Clin Oncol 37:e13590\u2013e13590. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.e13590","journal-title":"J Clin Oncol"},{"key":"4101_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.wneu.2016.11.010","volume":"98","author":"DK Ebner","year":"2017","unstructured":"Ebner DK, Gorovets D, Rava P et al (2017) Patients with long-term control of systemic disease are a favorable prognostic group for treatment of brain metastases with stereotactic radiosurgery alone. World Neurosurg 98:266\u2013272. https:\/\/doi.org\/10.1016\/j.wneu.2016.11.010","journal-title":"World Neurosurg"},{"key":"4101_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2013.09.051","volume":"88","author":"C Brennan","year":"2014","unstructured":"Brennan C, Yang TJ, Hilden P et al (2014) A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases. Int J Radiat Oncol 88:130\u2013136. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.09.051","journal-title":"Int J Radiat Oncol"},{"key":"4101_CR6","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1040\u20131048. https:\/\/doi.org\/10.1016\/S1470-2045(17)30414-X","journal-title":"Lancet Oncol"},{"key":"4101_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11060-021-03872-x","volume":"155","author":"JA Wilcox","year":"2021","unstructured":"Wilcox JA, Brown S, Reiner AS et al (2021) Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation. J Neurooncol 155:277\u2013286. https:\/\/doi.org\/10.1007\/s11060-021-03872-x","journal-title":"J Neurooncol"},{"key":"4101_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fonc.2015.00084","volume":"5","author":"DE Holt","year":"2015","unstructured":"Holt DE, Gill BS, Clump DA et al (2015) Tumor bed radiosurgery following resection and prior stereotactic radiosurgery for locally persistent brain metastasis. Front Oncol 5:84. https:\/\/doi.org\/10.3389\/fonc.2015.00084","journal-title":"Front Oncol"},{"key":"4101_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1227\/NEU.0000000000000986","volume":"12","author":"AG Wernicke","year":"2016","unstructured":"Wernicke AG, Lazow SP, Taube S et al (2016) Surgical technique and clinically relevant resection cavity dynamics following implantation of cesium-131 (Cs-131) brachytherapy in patients with brain metastases. Oper Neurosurg 12:49\u201360. https:\/\/doi.org\/10.1227\/NEU.0000000000000986","journal-title":"Oper Neurosurg"},{"key":"4101_CR10","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3171\/2016.4.JNS152530","volume":"126","author":"DR Raleigh","year":"2016","unstructured":"Raleigh DR, Seymour ZA, Tomlin B et al (2016) Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis. J Neurosurg 126:1749\u20131755. https:\/\/doi.org\/10.3171\/2016.4.JNS152530","journal-title":"J Neurosurg"},{"key":"4101_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.brachy.2019.01.011","volume":"18","author":"SS Mahase","year":"2019","unstructured":"Mahase SS, Navrazhina K, Schwartz TH et al (2019) Intraoperative brachytherapy for resected brain metastases. Brachytherapy 18:258\u2013270. https:\/\/doi.org\/10.1016\/j.brachy.2019.01.011","journal-title":"Brachytherapy"},{"key":"4101_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5114\/jcb.2020.93543","volume":"12","author":"B Chitti","year":"2020","unstructured":"Chitti B, Goyal S, Sherman JH et al (2020) The role of brachytherapy in the management of brain metastases: a systematic review. J Contemp Brachytherapy 12:67\u201383. https:\/\/doi.org\/10.5114\/jcb.2020.93543","journal-title":"J Contemp Brachytherapy"},{"key":"4101_CR13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3171\/2016.3.JNS152836","volume":"126","author":"AG Wernicke","year":"2017","unstructured":"Wernicke AG, Smith AW, Taube S et al (2017) Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease. J Neurosurg 126:1212\u20131219. https:\/\/doi.org\/10.3171\/2016.3.JNS152836","journal-title":"J Neurosurg"},{"key":"4101_CR14","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3171\/2018.7.JNS18656","volume":"131","author":"DG Brachman","year":"2018","unstructured":"Brachman DG, Youssef E, Dardis CJ et al (2018) Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas. J Neurosurg 131:1819\u20131828. https:\/\/doi.org\/10.3171\/2018.7.JNS18656","journal-title":"J Neurosurg"},{"key":"4101_CR15","unstructured":"Data on file (2019), GT Medical Technologies, Inc, and presented at the American Association of Neurological Surgeons."},{"key":"4101_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab185","author":"DJ Gessler","year":"2022","unstructured":"Gessler DJ, Neil EC, Shah R et al (2022) GammaTile\u00ae brachytherapy in the treatment of recurrent glioblastomas. Neuro-Oncol Adv. https:\/\/doi.org\/10.1093\/noajnl\/vdab185","journal-title":"Neuro-Oncol Adv"},{"key":"4101_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.1928","author":"NS Moss","year":"2022","unstructured":"Moss NS, Beal K, Tabar V (2022) Brain metastasis-a distinct oncologic disease best served by an integrated multidisciplinary team approach. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2022.1928","journal-title":"JAMA Oncol"},{"key":"4101_CR18","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/neuonc\/nov095","volume":"17","author":"BM Ellingson","year":"2015","unstructured":"Ellingson BM, Bendszus M, Boxerman J et al (2015) Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro-Oncol 17:1188\u20131198. https:\/\/doi.org\/10.1093\/neuonc\/nov095","journal-title":"Neuro-Oncol"},{"key":"4101_CR19","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/cancers13061435","volume":"13","author":"ST J\u00fcnger","year":"2021","unstructured":"J\u00fcnger ST, Pennig L, Sch\u00f6del P et al (2021) The debatable benefit of gross-total resection of brain metastases in a comprehensive treatment setting. Cancers 13:1435. https:\/\/doi.org\/10.3390\/cancers13061435","journal-title":"Cancers"},{"key":"4101_CR20","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1016\/j.wneu.2020.07.150","volume":"143","author":"B Kiesel","year":"2020","unstructured":"Kiesel B, Prihoda R, Borkovec M et al (2020) Postoperative magnetic resonance imaging after surgery of brain metastases: analysis of extent of resection and potential risk factors for incomplete resection. World Neurosurg 143:e365\u2013e373. https:\/\/doi.org\/10.1016\/j.wneu.2020.07.150","journal-title":"World Neurosurg"},{"key":"4101_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejca.2021.03.002","volume":"149","author":"P Karschnia","year":"2021","unstructured":"Karschnia P, Vogelbaum MA, van den Bent M et al (2021) Evidence-based recommendations on categories for extent of resection in diffuse glioma. Eur J Cancer 149:23\u201333. https:\/\/doi.org\/10.1016\/j.ejca.2021.03.002","journal-title":"Eur J Cancer"},{"key":"4101_CR22","doi-asserted-by":"publisher","first-page":"e245369","DOI":"10.1136\/bcr-2021-245369","volume":"14","author":"KKH Yu","year":"2021","unstructured":"Yu KKH, Imber BS, Moss NS (2021) Multimodality durable salvage of recurrent brain metastases refractory to LITT, SRS and immunotherapy with resection and cesium-131 brachytherapy: case report and literature review. BMJ Case Rep CP 14:e245369. https:\/\/doi.org\/10.1136\/bcr-2021-245369","journal-title":"BMJ Case Rep CP"},{"key":"4101_CR23","doi-asserted-by":"publisher","first-page":"e0195608","DOI":"10.1371\/journal.pone.0195608","volume":"13","author":"J Moreau","year":"2018","unstructured":"Moreau J, Khalil T, Dupic G et al (2018) Second course of stereotactic radiosurgery for locally recurrent brain metastases: safety and efficacy. PLoS ONE 13:e0195608. https:\/\/doi.org\/10.1371\/journal.pone.0195608","journal-title":"PLoS ONE"},{"key":"4101_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.wneu.2017.04.103","volume":"104","author":"P Koffer","year":"2017","unstructured":"Koffer P, Chan J, Rava P et al (2017) Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurg 104:589\u2013593. https:\/\/doi.org\/10.1016\/j.wneu.2017.04.103","journal-title":"World Neurosurg"},{"key":"4101_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-019-03323-8","author":"C Iorio-Morin","year":"2019","unstructured":"Iorio-Morin C, Mercure-Cyr R, Figueiredo G et al (2019) Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-019-03323-8","journal-title":"J Neurooncol"},{"key":"4101_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1001\/jamaoncol.2018.4610","volume":"5","author":"TM Churilla","year":"2019","unstructured":"Churilla TM, Chowdhury IH, Handorf E et al (2019) Comparison of local control of brain metastases with stereotactic radiosurgery vs surgical resection: a secondary analysis of a randomized clinical trial. JAMA Oncol 5:243\u2013247. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4610","journal-title":"JAMA Oncol"},{"key":"4101_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3171\/2016.5.JNS153051","volume":"127","author":"WH McKay","year":"2017","unstructured":"McKay WH, McTyre ER, Okoukoni C et al (2017) Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg 127:148\u2013156. https:\/\/doi.org\/10.3171\/2016.5.JNS153051","journal-title":"J Neurosurg"},{"key":"4101_CR28","doi-asserted-by":"publisher","first-page":"e11570","DOI":"10.7759\/cureus.11570","volume":"12","author":"P Nakaji","year":"2020","unstructured":"Nakaji P, Smith K, Youssef E et al (2020) Resection and surgically targeted radiation therapy for the treatment of larger recurrent or newly diagnosed brain metastasis: results from a prospective trial. Cureus 12:e11570. https:\/\/doi.org\/10.7759\/cureus.11570","journal-title":"Cureus"},{"key":"4101_CR29","doi-asserted-by":"publisher","DOI":"10.3171\/2021.10.JNS211886","author":"WC Chen","year":"2022","unstructured":"Chen WC, Lafreniere M, Phuong C et al (2022) Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors. J Neurosurg. https:\/\/doi.org\/10.3171\/2021.10.JNS211886","journal-title":"J Neurosurg"},{"key":"4101_CR30","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1227\/00006123-198706000-00020","volume":"20","author":"PH Gutin","year":"1987","unstructured":"Gutin PH, Leibel SA, Hosobuchi Y et al (1987) Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources. Neurosurgery 20:938\u2013945. https:\/\/doi.org\/10.1227\/00006123-198706000-00020","journal-title":"Neurosurgery"},{"key":"4101_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jso.2930600409","volume":"60","author":"D Nori","year":"1995","unstructured":"Nori D, Li X, Pugkhem T (1995) Intraoperative brachytherapy using gelfoam radioactive plaque implants for resected stage iii non-small cell lung cancer with positive margin: a pilot study. J Surg Oncol 60:257\u2013261. https:\/\/doi.org\/10.1002\/jso.2930600409","journal-title":"J Surg Oncol"},{"key":"4101_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/nop\/npab005","volume":"8","author":"ED Bander","year":"2021","unstructured":"Bander ED, Yuan M, Reiner AS et al (2021) Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control. Neuro-Oncol Pract 8:278\u2013289. https:\/\/doi.org\/10.1093\/nop\/npab005","journal-title":"Neuro-Oncol Pract"},{"key":"4101_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaa073.056","author":"NS Moss","year":"2020","unstructured":"Moss NS, Imber BS, Prasad K et al (2020) Permanent intracavitary Cs131 brachytherapy for previously-irradiated recurrent brain metastases: initial clinical and radiation safety experience. Neuro-Oncol Adv. https:\/\/doi.org\/10.1093\/noajnl\/vdaa073.056","journal-title":"Neuro-Oncol Adv"},{"key":"4101_CR34","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11060-021-03790-y","volume":"153","author":"WC Newman","year":"2021","unstructured":"Newman WC, Goldberg J, Guadix SW et al (2021) The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes. J Neurooncol 153:507\u2013518. https:\/\/doi.org\/10.1007\/s11060-021-03790-y","journal-title":"J Neurooncol"},{"key":"4101_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13014-019-1228-x","volume":"14","author":"M Furuse","year":"2019","unstructured":"Furuse M, Nonoguchi N, Yamada K et al (2019) Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review. Radiat Oncol 14:28. https:\/\/doi.org\/10.1186\/s13014-019-1228-x","journal-title":"Radiat Oncol"},{"key":"4101_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1148\/radiol.2532090007","volume":"253","author":"RF Barajas","year":"2009","unstructured":"Barajas RF, Chang JS, Segal MR et al (2009) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 253:486\u2013496. https:\/\/doi.org\/10.1148\/radiol.2532090007","journal-title":"Radiology"}],"updated-by":[{"DOI":"10.1007\/s11060-022-04121-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000}}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-022-04101-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04101-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:23:00Z","timestamp":1744186980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-022-04101-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["4101"],"URL":"https:\/\/doi.org\/10.1007\/s11060-022-04101-9","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"14 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11060-022-04121-5","URL":"https:\/\/doi.org\/10.1007\/s11060-022-04121-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was funded in part through the NIH\/NCI Cancer Center Support Grant P30 CA008748. BSI reports an honorarium from GT Medical Technologies. NSM is PI of an investigator-initiated trial funded by GT Medical Technologies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}